Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase One Study With Direct Individual Benefit: Effects of OM-174 in Adult Patients With Solid Tumors.

NCT01800812 is registered in ClinicalTrials.gov with Centre Hospitalier Universitaire Dijon as lead sponsor.

NCT NCT01800812
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01800812 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase One Study With Direct Individual Benefit: Effects of OM-174 in Adult Patients With Solid Tumors.
Lead sponsor
Centre Hospitalier Universitaire Dijon
Phase
Phase 1
Overall status
Completed
Start date
March 31, 2007
Completion date
Not reported
Enrollment
27
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

solid tumors